PPARγ is an E3 ligase and could degrade nuclear factor κB (NFκB)/p65 via ubiquitination, resulting in the inhibition of NFκB-mediated inflammatory responses and tumor growth [145]. The gene discussed is NFKB1; the disease is neoplasm.